Εμβόλια A Randomized Trial Assessing the Immunogenicity and Reactogenicity of Two Hexavalent Infant Vaccines Concomitantly Administered With Group B Meningococcal Vaccine Authors: Matthew Rajan et al. 01/01/2023 time to read 2 min read
Εμβόλια Real-world impact and effectiveness of the quadrivalent HPV vaccine: an updated systematic literature review Authors: Wei Vivian Wang et al. 21/12/2022 time to read 2 min read
Εμβόλια Demonstration of durable hepatitis B immune memory in children vaccinated with a DTaP5-IPV-HepB-Hib infant-toddler series 7 to 8 years previously Authors: Anitta Ahonen et al. 30/11/2022 time to read 2 min read
Εμβόλια Head-to-head comparison of the immunogenicity of RotaTeq and Rotarix rotavirus vaccines and factors associated with seroresponse in infants in Bangladesh: a randomised, controlled, open-label, parallel, phase 4 trial Authors: Daniel E Velasquez-Portocarrero et al. 01/11/2022 time to read 3 min read
Εμβόλια A phase III, multicenter, randomized, double-blind, active comparator-controlled study to evaluate the safety, tolerability, and immunogenicity of catch-up vaccination regimens of V114, a 15-valent pneumococcal conjugate vaccine, in healthy infants, children, and adolescents (PNEU-PLAN) Authors: Natalie Banniettis et al. 19/10/2022 time to read 2 min read
Εμβόλια Role of human papillomavirus (HPV) vaccination on HPV infection and recurrence of HPV related disease after local surgical treatment: systematic review and meta-analysis 03/08/2022 time to read 3 min read
Εμβόλια Real-world impact of rotavirus vaccination in European healthcare settings: a systematic literature review 16/06/2022 time to read < 1 min read
Εμβόλια Increase in Streptococcus pneumoniae serotype 3 associated parapneumonic pleural effusion/empyema after the introduction of PCV13 in Germany 16/01/2020 time to read 2 min read
Εμβόλια DTaP5-HBV-IPV-Hib pediatric hexavalent combination vaccine for use in children from 6 weeks through to 4 years of age 05/11/2019 time to read < 1 min read
Εμβόλια Impact of scaled up human papillomavirus vaccination and cervical screening and the potential for global elimination of cervical cancer in 181 countries, 2020-99: a modelling study Authors: Kate T Simms et al. 20/03/2019 time to read 4 min read
Εμβόλια A Phase III Randomized, Double-blind, Clinical Trial of an Investigational Hexavalent Vaccine Given at Two, Three, Four and Twelve Months Authors: Timo Vesikari et al. 01/02/2017 time to read 2 min read